Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Membrane Glycoproteins | 14 | 2017 | 370 | 2.700 |
Why?
|
| Endoplasmic Reticulum | 7 | 2017 | 148 | 1.560 |
Why?
|
| Dendritic Cells | 3 | 2021 | 201 | 1.380 |
Why?
|
| Molecular Chaperones | 6 | 2017 | 81 | 1.340 |
Why?
|
| HSP90 Heat-Shock Proteins | 4 | 2021 | 46 | 1.110 |
Why?
|
| Gastrointestinal Tract | 2 | 2017 | 63 | 0.990 |
Why?
|
| Homeostasis | 3 | 2021 | 291 | 0.950 |
Why?
|
| Membrane Proteins | 5 | 2020 | 617 | 0.950 |
Why?
|
| Multiple Myeloma | 2 | 2015 | 92 | 0.890 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2020 | 199 | 0.820 |
Why?
|
| Immunotherapy | 2 | 2021 | 215 | 0.800 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 80 | 0.770 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 79 | 0.750 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 95 | 0.740 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 756 | 0.660 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2019 | 42 | 0.650 |
Why?
|
| CD11c Antigen | 2 | 2017 | 18 | 0.620 |
Why?
|
| Mice | 21 | 2022 | 8474 | 0.590 |
Why?
|
| Sepsis | 1 | 2019 | 233 | 0.540 |
Why?
|
| Liver | 2 | 2019 | 1118 | 0.530 |
Why?
|
| Wnt Signaling Pathway | 2 | 2013 | 57 | 0.530 |
Why?
|
| Plasma Cells | 1 | 2015 | 19 | 0.510 |
Why?
|
| Animals | 25 | 2022 | 20881 | 0.490 |
Why?
|
| Kidney | 1 | 2019 | 945 | 0.470 |
Why?
|
| Mice, Knockout | 9 | 2020 | 1692 | 0.470 |
Why?
|
| Basophils | 1 | 2012 | 57 | 0.410 |
Why?
|
| Cell Line, Tumor | 7 | 2021 | 1851 | 0.400 |
Why?
|
| Gene Deletion | 5 | 2017 | 235 | 0.400 |
Why?
|
| Mice, Transgenic | 4 | 2021 | 1033 | 0.390 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 508 | 0.390 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 56 | 0.360 |
Why?
|
| Unfolded Protein Response | 3 | 2017 | 70 | 0.360 |
Why?
|
| Blood Platelets | 2 | 2020 | 284 | 0.310 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 266 | 0.310 |
Why?
|
| Colitis | 3 | 2019 | 156 | 0.300 |
Why?
|
| Carcinogenesis | 3 | 2020 | 124 | 0.280 |
Why?
|
| Neoplasms | 6 | 2020 | 1667 | 0.270 |
Why?
|
| Lymphocyte Activation | 4 | 2021 | 397 | 0.270 |
Why?
|
| Proteolysis | 2 | 2020 | 97 | 0.270 |
Why?
|
| Cell Differentiation | 2 | 2021 | 1034 | 0.270 |
Why?
|
| Immunoprecipitation | 4 | 2017 | 132 | 0.270 |
Why?
|
| Colonic Neoplasms | 2 | 2019 | 299 | 0.230 |
Why?
|
| Lipopolysaccharides | 2 | 2019 | 455 | 0.230 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 2550 | 0.210 |
Why?
|
| Apoptosis | 3 | 2020 | 1641 | 0.210 |
Why?
|
| B-Lymphocytes | 2 | 2022 | 329 | 0.200 |
Why?
|
| Cross-Priming | 1 | 2021 | 10 | 0.200 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 76 | 0.190 |
Why?
|
| Tumor Microenvironment | 2 | 2020 | 213 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 7 | 2022 | 2791 | 0.190 |
Why?
|
| Neoplasms, Experimental | 1 | 2021 | 118 | 0.190 |
Why?
|
| Bone and Bones | 1 | 2021 | 145 | 0.190 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 1293 | 0.180 |
Why?
|
| Immune Tolerance | 2 | 2019 | 114 | 0.180 |
Why?
|
| Osteoclasts | 1 | 2021 | 132 | 0.180 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 1 | 2020 | 4 | 0.180 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2022 | 132 | 0.180 |
Why?
|
| Phenylthiohydantoin | 1 | 2020 | 12 | 0.180 |
Why?
|
| Models, Animal | 2 | 2019 | 252 | 0.180 |
Why?
|
| Nitriles | 1 | 2020 | 68 | 0.180 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2020 | 14 | 0.180 |
Why?
|
| Endometrial Neoplasms | 1 | 2020 | 69 | 0.170 |
Why?
|
| Immune Evasion | 1 | 2020 | 19 | 0.170 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 108 | 0.170 |
Why?
|
| Thrombin | 1 | 2020 | 117 | 0.170 |
Why?
|
| Benzamides | 1 | 2020 | 156 | 0.170 |
Why?
|
| Cecum | 1 | 2019 | 39 | 0.170 |
Why?
|
| Humans | 18 | 2022 | 68618 | 0.170 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 42 | 0.160 |
Why?
|
| Antigen Presentation | 1 | 2019 | 76 | 0.160 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 87 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 332 | 0.150 |
Why?
|
| Melanoma | 1 | 2022 | 335 | 0.150 |
Why?
|
| Blotting, Western | 3 | 2017 | 954 | 0.150 |
Why?
|
| Transcription Factor CHOP | 1 | 2017 | 28 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 244 | 0.150 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2017 | 38 | 0.150 |
Why?
|
| Cell Proliferation | 3 | 2020 | 1174 | 0.150 |
Why?
|
| eIF-2 Kinase | 1 | 2017 | 49 | 0.140 |
Why?
|
| Immunoglobulin A | 1 | 2017 | 79 | 0.140 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 1536 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 2 | 2016 | 384 | 0.140 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 99 | 0.140 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2017 | 126 | 0.140 |
Why?
|
| Tumor Escape | 1 | 2016 | 37 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2017 | 135 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 626 | 0.140 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 88 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 179 | 0.140 |
Why?
|
| Inflammasomes | 1 | 2016 | 39 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 216 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 219 | 0.130 |
Why?
|
| Protein Binding | 3 | 2020 | 1027 | 0.130 |
Why?
|
| RNA Interference | 2 | 2013 | 266 | 0.130 |
Why?
|
| Oncogenes | 1 | 2016 | 71 | 0.130 |
Why?
|
| Protein Multimerization | 2 | 2013 | 71 | 0.130 |
Why?
|
| Chromatography, Liquid | 2 | 2017 | 120 | 0.120 |
Why?
|
| Bone Marrow Cells | 2 | 2013 | 217 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2017 | 139 | 0.120 |
Why?
|
| Inflammation | 2 | 2019 | 1030 | 0.120 |
Why?
|
| CD24 Antigen | 1 | 2014 | 6 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 1174 | 0.120 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 700 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 492 | 0.120 |
Why?
|
| Immunoblotting | 2 | 2013 | 254 | 0.120 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2013 | 7 | 0.110 |
Why?
|
| Macrophages | 2 | 2016 | 647 | 0.110 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2013 | 9 | 0.110 |
Why?
|
| Melanosomes | 1 | 2013 | 5 | 0.110 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2013 | 8 | 0.110 |
Why?
|
| Cell Survival | 2 | 2013 | 901 | 0.110 |
Why?
|
| Skin Pigmentation | 1 | 2013 | 25 | 0.110 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2013 | 40 | 0.110 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2013 | 16 | 0.110 |
Why?
|
| Myeloid Cells | 1 | 2014 | 57 | 0.110 |
Why?
|
| Melanins | 1 | 2013 | 24 | 0.110 |
Why?
|
| Wnt Proteins | 1 | 2013 | 57 | 0.110 |
Why?
|
| CD11a Antigen | 1 | 2013 | 3 | 0.110 |
Why?
|
| CD18 Antigens | 1 | 2013 | 9 | 0.110 |
Why?
|
| Receptors, LDL | 1 | 2013 | 72 | 0.110 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 122 | 0.110 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 160 | 0.110 |
Why?
|
| Bromodeoxyuridine | 1 | 2013 | 37 | 0.110 |
Why?
|
| Signal Transduction | 6 | 2020 | 2689 | 0.110 |
Why?
|
| Flow Cytometry | 2 | 2013 | 489 | 0.110 |
Why?
|
| Mice, SCID | 1 | 2013 | 238 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 127 | 0.110 |
Why?
|
| Cell Line | 5 | 2017 | 1752 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 282 | 0.110 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 186 | 0.110 |
Why?
|
| Repressor Proteins | 1 | 2013 | 183 | 0.100 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2012 | 8 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2014 | 163 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 194 | 0.100 |
Why?
|
| Antigens | 1 | 2012 | 90 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 235 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2013 | 312 | 0.100 |
Why?
|
| Plasmids | 1 | 2013 | 258 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2013 | 326 | 0.100 |
Why?
|
| Alternative Splicing | 1 | 2012 | 93 | 0.100 |
Why?
|
| Species Specificity | 1 | 2012 | 303 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 434 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 710 | 0.100 |
Why?
|
| Transfection | 2 | 2010 | 782 | 0.090 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2010 | 12 | 0.090 |
Why?
|
| Chromatography, Gel | 1 | 2010 | 79 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2014 | 334 | 0.090 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 81 | 0.090 |
Why?
|
| Protein Folding | 1 | 2010 | 82 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 261 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2013 | 753 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 507 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2013 | 902 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 532 | 0.070 |
Why?
|
| Cell Membrane | 2 | 2020 | 525 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2016 | 138 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 1026 | 0.070 |
Why?
|
| Bronchi | 1 | 2004 | 59 | 0.060 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2004 | 51 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2017 | 226 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2019 | 597 | 0.060 |
Why?
|
| Interleukin-10 | 1 | 2004 | 144 | 0.060 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2004 | 133 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 1038 | 0.060 |
Why?
|
| Female | 6 | 2022 | 38074 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 498 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2004 | 431 | 0.050 |
Why?
|
| Th17 Cells | 1 | 2021 | 116 | 0.050 |
Why?
|
| Bacteria | 1 | 2021 | 193 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2020 | 132 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 91 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 59 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 126 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 215 | 0.040 |
Why?
|
| Male | 4 | 2022 | 37321 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2017 | 13 | 0.040 |
Why?
|
| L-Selectin | 1 | 2017 | 28 | 0.040 |
Why?
|
| Glycolysis | 1 | 2017 | 79 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2017 | 50 | 0.040 |
Why?
|
| NLR Proteins | 1 | 2016 | 3 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 373 | 0.040 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2016 | 18 | 0.040 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 21 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2016 | 22 | 0.040 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 22 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 53 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 70 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 142 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 2014 | 10 | 0.030 |
Why?
|
| Alkylating Agents | 1 | 2014 | 15 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 69 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 786 | 0.030 |
Why?
|
| Interleukin-23 | 1 | 2013 | 13 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 60 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2013 | 66 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2013 | 62 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2013 | 63 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 929 | 0.030 |
Why?
|
| DNA Repair | 1 | 2013 | 127 | 0.030 |
Why?
|
| Colon | 1 | 2013 | 168 | 0.030 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 16 | 0.030 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2012 | 23 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 306 | 0.030 |
Why?
|
| Binding Sites | 1 | 2013 | 631 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 196 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 630 | 0.020 |
Why?
|
| Peptides | 1 | 2013 | 455 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 866 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1745 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 1173 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2004 | 52 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2004 | 283 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 1213 | 0.010 |
Why?
|